Suppr超能文献

突变型ataxin-1抑制脊髓小脑共济失调1型中神经祖细胞的增殖。

Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1.

作者信息

Cvetanovic Marija, Hu Yuan-Shih, Opal Puneet

机构信息

Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA.

Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.

出版信息

Cerebellum. 2017 Apr;16(2):340-347. doi: 10.1007/s12311-016-0794-9.

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease caused by the expansion of a polyglutamine (Q) repeat tract in the protein ataxin-1 (ATXN1). Beginning as a cerebellar ataxic disorder, SCA1 progresses to involve the cerebral cortex, hippocampus, and brainstem. Using SCA1 knock-in mice that mirror the complexity of the human disease, we report a significant decrease in the capacity of adult neuronal progenitor cells (NPCs) to proliferate. Remarkably, a decrease in NPCs proliferation can be observed in vitro, outside the degenerative milieu of surrounding neurons or glia, demonstrating that mutant ATXN1 acting cell autonomously within progenitor cells interferes with their ability to proliferate. Our findings suggest that compromised adult neurogenesis contributes to the progressive pathology of the disease particularly in areas such as the hippocampus and cerebral cortex where stem cells provide neurotropic factors and participate in adult neurogenesis. These findings not only shed light on the biology of the disease but also have therapeutic implications in any future stem cell-based clinical trials.

摘要

1型脊髓小脑共济失调(SCA1)是一种常染色体显性遗传的神经退行性疾病,由ataxin-1(ATXN1)蛋白中多聚谷氨酰胺(Q)重复序列的扩增引起。SCA1最初表现为小脑共济失调,随后逐渐发展至累及大脑皮层、海马体和脑干。利用能够反映人类疾病复杂性的SCA1基因敲入小鼠,我们发现成年神经前体细胞(NPCs)的增殖能力显著下降。值得注意的是,在体外,即在周围神经元或神经胶质细胞的变性环境之外,也能观察到NPCs增殖的减少,这表明突变的ATXN1在祖细胞内自主发挥作用,干扰了它们的增殖能力。我们的研究结果表明,受损的成年神经发生导致了该疾病的进行性病理变化,特别是在海马体和大脑皮层等区域,干细胞在这些区域提供神经营养因子并参与成年神经发生。这些发现不仅揭示了该疾病的生物学特性,而且对未来任何基于干细胞的临床试验都具有治疗意义。

相似文献

1
Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1.
Cerebellum. 2017 Apr;16(2):340-347. doi: 10.1007/s12311-016-0794-9.
2
Ataxin-1 regulates proliferation of hippocampal neural precursors.
Neuroscience. 2016 May 13;322:54-65. doi: 10.1016/j.neuroscience.2016.02.011. Epub 2016 Feb 11.
3
Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1.
J Clin Invest. 2018 Jun 1;128(6):2252-2265. doi: 10.1172/JCI96765. Epub 2018 Apr 23.
6
Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.
Neuroscience. 2015 Mar 19;289:289-99. doi: 10.1016/j.neuroscience.2015.01.003. Epub 2015 Jan 14.
7
BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1.
Neurobiol Dis. 2023 Mar;178:106023. doi: 10.1016/j.nbd.2023.106023. Epub 2023 Jan 29.
8
Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462.
10
Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1.
JCI Insight. 2021 Feb 8;6(3):144955. doi: 10.1172/jci.insight.144955.

引用本文的文献

2
Experimental Treatment with Edaravone in a Mouse Model of Spinocerebellar Ataxia 1.
Int J Mol Sci. 2023 Jun 26;24(13):10689. doi: 10.3390/ijms241310689.
3
BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1.
Neurobiol Dis. 2023 Mar;178:106023. doi: 10.1016/j.nbd.2023.106023. Epub 2023 Jan 29.
5
The extra-cerebellar effects of spinocerebellar ataxia type 1 (SCA1): looking beyond the cerebellum.
Cell Mol Life Sci. 2022 Jul 8;79(8):404. doi: 10.1007/s00018-022-04419-7.
6
Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.
Cerebellum. 2022 Jun;21(3):452-481. doi: 10.1007/s12311-021-01311-1. Epub 2021 Aug 10.
7
Mood alterations in mouse models of Spinocerebellar Ataxia type 1.
Sci Rep. 2021 Jan 12;11(1):713. doi: 10.1038/s41598-020-80664-9.
8
Polyglutamine-containing microglia leads to disturbed differentiation and neurite retraction of neuron-like cells.
Heliyon. 2020 Sep 6;6(9):e04851. doi: 10.1016/j.heliyon.2020.e04851. eCollection 2020 Sep.
9
Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment.
Mol Ther Nucleic Acids. 2020 Sep 4;21:1006-1016. doi: 10.1016/j.omtn.2020.07.030. Epub 2020 Jul 25.
10
Pathogenic mechanisms underlying spinocerebellar ataxia type 1.
Cell Mol Life Sci. 2020 Oct;77(20):4015-4029. doi: 10.1007/s00018-020-03520-z. Epub 2020 Apr 18.

本文引用的文献

1
Increased bone morphogenetic protein signaling contributes to age-related declines in neurogenesis and cognition.
Neurobiol Aging. 2016 Feb;38:164-175. doi: 10.1016/j.neurobiolaging.2015.10.035. Epub 2015 Nov 10.
3
Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.
Neuroscience. 2015 Mar 19;289:289-99. doi: 10.1016/j.neuroscience.2015.01.003. Epub 2015 Jan 14.
5
Role of adult neurogenesis in hippocampal-cortical memory consolidation.
Mol Brain. 2014 Feb 19;7:13. doi: 10.1186/1756-6606-7-13.
7
Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling.
PLoS One. 2013 May 21;8(5):e64460. doi: 10.1371/journal.pone.0064460. Print 2013.
8
Signaling mechanisms regulating adult neural stem cells and neurogenesis.
Biochim Biophys Acta. 2013 Feb;1830(2):2435-48. doi: 10.1016/j.bbagen.2012.09.002. Epub 2012 Sep 12.
9
LANP mediates neuritic pathology in Spinocerebellar ataxia type 1.
Neurobiol Dis. 2012 Dec;48(3):526-32. doi: 10.1016/j.nbd.2012.07.024. Epub 2012 Aug 4.
10
Neural precursors (NPCs) from adult L967Q mice display early commitment to "in vitro" neuronal differentiation and hyperexcitability.
Exp Neurol. 2012 Aug;236(2):307-18. doi: 10.1016/j.expneurol.2012.05.010. Epub 2012 May 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验